Price Alert

Alaunos Therapeutics Inc. (TCRT)

NASDAQ: TCRT · Real-Time Price · USD

2.27

-0.13 (-5.42%)

At close: Aug 15, 2025, 3:59 PM

Alaunos Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	319K	1.09M	1.68M	2.46M	4.14M	6.06M	11.94M	18.32M	23.5M	39.06M	37.81M	60.01M	68.25M	76.05M	91.72M	76.75M	100.06M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	1.05M	n/a	n/a	n/a	n/a	0.00	n/a	501K	542K	542K	542K	542K	668K	673K	367K	381K	315K
Receivables	2K	5K	n/a	4K	1K	1K	n/a	4K	n/a	4K	2.91M	n/a	n/a	1.11M	1.51M	7.63M	5.01M
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	13.94M	n/a	-1.11M	n/a	n/a	n/a	n/a	n/a
Other Current Assets	746K	1.66M	1.87M	2.21M	1.89M	2.2M	925K	457K	14.69M	799K	13.94M	1.35M	1.52M	1.67M	3.32M	5.04M	7.65M
Total Current Assets	1.07M	2.75M	3.55M	4.68M	6.04M	8.26M	12.87M	18.78M	38.18M	53.8M	55.51M	61.36M	69.77M	78.83M	96.55M	89.41M	112.71M
Property-Plant & Equipment	n/a	n/a	n/a	n/a	n/a	2K	6.57M	8.65M	9.91M	10.6M	11.3M	12.03M	14.55M	15.36M	16.84M	16.98M	15.45M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	1.05M	n/a	n/a	n/a	n/a	2K	6.57M	9.15M	10.45M	11.14M	11.84M	12.57M	15.22M	16.03M	17.21M	17.36M	15.76M
Total Assets	2.12M	2.75M	3.55M	4.68M	6.04M	8.26M	19.44M	27.93M	48.64M	64.94M	67.34M	73.93M	84.99M	94.86M	113.76M	106.77M	128.47M
Account Payables	831K	516K	458K	365K	597K	616K	1.3M	1.48M	1.38M	1.39M	1.98M	474K	605K	1.37M	1.46M	982K	4.19M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	339K	11.56M	17.32M	23.21M	20.58M	14.74M	8.6M	12.75M	765K	759K
Other Current Liabilities	231K	n/a	n/a	n/a	n/a	1.3M	n/a	-339K	-575K	3.74M	-542K	-525K	-745K	3.65M	-710K	-765K	-759K
Total Current Liabilities	1.06M	692K	826K	907K	1.24M	1.96M	4.68M	5.05M	17.06M	24.17M	32.87M	26.77M	21.23M	16.04M	28.17M	13.59M	18.96M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	4.47M	10.32M	16.25M	12.17M	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	28K	28K	28K	28K	n/a	-1K	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	864K	1.23M	2.07M	2.22M	2.36M	6.98M	14.63M	20.77M	16.88M	4.89M	3.87M
Total Liabilities	1.06M	692K	826K	907K	1.24M	1.96M	5.54M	6.28M	19.13M	26.38M	35.23M	33.75M	35.87M	36.81M	45.05M	18.48M	22.83M
Total Debt	n/a	n/a	n/a	n/a	n/a	n/a	1.17M	1.56M	13.6M	19.51M	25.54M	27.52M	29.37M	29.36M	29.63M	5.66M	4.63M
Common Stock	2K	2K	2K	2K	16K	16K	241K	241K	241K	240K	216K	216K	216K	216K	216K	216K	215K
Retained Earnings	-921.52M	-920.45M	-919.7M	-918.58M	-917.45M	-915.77M	-907.92M	-899.45M	-890.67M	-880.63M	-871.47M	-862.57M	-852.64M	-842.85M	-831.06M	-808.33M	-785.65M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	1.06M	2.06M	2.72M	3.77M	4.8M	6.31M	13.9M	21.65M	29.51M	38.55M	32.11M	40.18M	49.12M	58.06M	68.71M	88.28M	105.64M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a